Therapeutic antibodies

Results: 49



#Item
21Senior Project Manager, Preclinical R&D Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug

Senior Project Manager, Preclinical R&D Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug

Add to Reading List

Source URL: www.zymeworks.com

Language: English - Date: 2014-11-19 13:25:19
22Director, Therapeutic Antibody Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody dr

Director, Therapeutic Antibody Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody dr

Add to Reading List

Source URL: www.zymeworks.com

Language: English - Date: 2014-11-19 13:25:19
23Scientists, Therapeutic Antibody Discovery & Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies a

Scientists, Therapeutic Antibody Discovery & Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies a

Add to Reading List

Source URL: www.zymeworks.com

Language: English - Date: 2014-12-19 13:10:21
24Cytokine and CAM Antagonists and Related Agents Therapeutic Class Review (TCR) September 22, 2014 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, includ

Cytokine and CAM Antagonists and Related Agents Therapeutic Class Review (TCR) September 22, 2014 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, includ

Add to Reading List

Source URL: www.hhsc.state.tx.us

Language: English - Date: 2014-11-05 17:48:09
25Research Assistant Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug conjugates for treatm

Research Assistant Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug conjugates for treatm

Add to Reading List

Source URL: www.zymeworks.com

Language: English - Date: 2014-12-19 13:10:21
    26October 5, 2001 IMPORTANT DRUG WARNING Dear Healthcare Professional: Centocor would like to inform you of important safety information for REMICADE® (infliximab), a biological therapeutic product indicated for the trea

    October 5, 2001 IMPORTANT DRUG WARNING Dear Healthcare Professional: Centocor would like to inform you of important safety information for REMICADE® (infliximab), a biological therapeutic product indicated for the trea

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    27NEWS RELEASE Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical Web Site Release July 15, 2014

    NEWS RELEASE Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical Web Site Release July 15, 2014

    Add to Reading List

    Source URL: www.leafbio.com

    Language: English - Date: 2014-07-23 23:07:58
    28The immunogenicity of therapeutic proteins- what you don’t know can hurt YOU and the patient João A. Pedras-Vasconcelos, PhD CMC and Immunogenicity Reviewer Division of Therapeutic Proteins

    The immunogenicity of therapeutic proteins- what you don’t know can hurt YOU and the patient João A. Pedras-Vasconcelos, PhD CMC and Immunogenicity Reviewer Division of Therapeutic Proteins

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    29Guidance for Industry Immunogenicity Assessment for Therapeutic Protein Products U.S. Department of Health and Human Services Food and Drug Administration

    Guidance for Industry Immunogenicity Assessment for Therapeutic Protein Products U.S. Department of Health and Human Services Food and Drug Administration

    Add to Reading List

    Source URL: www.fda.gov.

    Language: English
    30NEWS RELEASE Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical Web Site Release July 15, 2014

    NEWS RELEASE Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical Web Site Release July 15, 2014

    Add to Reading List

    Source URL: www.mappbio.com

    Language: English - Date: 2014-07-17 00:43:21